Background: The Pediatric Eosinophilic Esophagitis Symptom Score (PEESS v2.0) measures patient-relevant outcomes. However, whether patient-identified domains (dysphagia, gastroesophageal reflux disease [GERD], nausea/vomiting, and pain) align with clinical symptomology and histopathologic and molecular features of eosinophilic esophagitis (EoE ...

The Pediatric Eosinophilic Esophagitis Symptom Score (PEESS ® v2.0) measures patient-relevant outcomes. However, whether patient-identified domains (dysphagia, gastrointestinal reflux disease (GERD), nausea/vomiting, and pain) align with clinical symptomology and histopathologic and molecular features of eosinophilic esophagitis (EoE) is unclear.

We recently developed the Pediatric EoE Symptom Score (PEESS v2.0) in an effort to identify and uniquely measure relevant outcomes that patients with EoE and their families identified as important.3 Input from patients and their families established that the 20 questions from the PEESS v2.0 could be

Access the Pediatric Eosinophilic Esophagitis Symptom Severity Module, version 2.0 (PEESS v2.0) by Franciosi JP and up-to-date information on copyright, licensing, scoring, translations, ...

2022年7月1日 · Eosinophilic esophagitis (EoE) is a rare, chronic type 2 inflammatory disease that is histologically characterized by eosinophilic infiltration of the esophageal epithelium. 1,2 Clinically, EoE manifests with an array of symptoms that can significantly impair the daily activities and health-related quality of life of patients and their families....

2018年11月1日 · PEESS is an important advance in the evaluation of EoE symptoms, as it values the report of the patients that live with this disease, in the scenario of a chronic disease, with an invasive diagnosis and follow-up, which requires careful evaluation of symptom evolution for appropriate therapeutic planning.

Background The Pediatric Eosinophilic Esophagitis Symptom Score (PEESS v2.0) measures patient-relevant outcomes. However, whether patient-identified domains (dysphagia, gastroesophageal reflux disease [GERD], nausea/vomiting, and pain) align with clinical symptomology and histopathologic and molecular features of eosinophilic esophagitis (EoE ...

2011年11月18日 · We have developed the face and content validated Pediatric Eosinophilic Esophagitis Symptom Score (PEESS™ v2.0). The PEESS™ v2.0 metric is now undergoing multisite national field testing as the next iterative instrument development phase.

2014年12月29日 · The Pediatric Eosinophilic Esophagitis Symptom Score (PEESS v2.0) measures patient-relevant outcomes. However, whether patient-identified domains (dysphagia, gastroesophageal reflux disease [GERD], nausea/vomiting, and pain) align with clinical symptomology and histopathologic and molecular features of …

2023年9月2日 · Common treatment approaches for EoE include dietary elimination, swallowed topical steroids, proton pump inhibitors, and esophageal dilation. The recent FDA approval of Dupixent® (dupilumab) as biologic therapy for EoE presents an important novel therapeutic option and adds further complexity to management strategies.